OPK Opko Health Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: OPK

Price (delayed)

$1.23

Market cap

$857.3M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.25

Enterprise value

$1.07B

Opko Health Inc. is a multinational biopharmaceutical and diagnostics company that seeks to establish industry-leading positions in large, rapidly growing markets by leveraging its discovery, development, and commercialization expertise and ...

Highlights
Opko Health's EPS has increased by 46% YoY and by 11% from the previous quarter
The net income is up by 42% year-on-year and by 9% since the previous quarter
Opko Health's gross margin has increased by 28% YoY but it has decreased by 3.2% from the previous quarter
The gross profit has grown by 10% YoY but it has contracted by 3.4% from the previous quarter
Opko Health's quick ratio has decreased by 16% YoY and by 14% from the previous quarter
The company's revenue fell by 14% YoY
Sector: Healthcare
Industry: Diagnostics & Research
Website: http://www.opko.com
Peers: JNJ ABT REGN ARDX

Key stats

What are the main financial stats of OPK
Market
Shares outstanding
696.99M
Market cap
$857.3M
Enterprise value
$1.07B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
0.68
Price to sales (P/S)
1.07
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.24
Earnings
Revenue
$863.5M
EBIT
-$170.92M
EBITDA
-$65.62M
Free cash flow
-$41.76M
Per share
EPS
-$0.25
Free cash flow per share
-$0.06
Book value per share
$1.8
Revenue per share
$1.15
TBVPS
$0.9
Balance sheet
Total assets
$2.01B
Total liabilities
$622.48M
Debt
$308.75M
Equity
$1.39B
Working capital
$109.42M
Liquidity
Debt to equity
0.22
Current ratio
1.55
Quick ratio
1.1
Net debt/EBITDA
-3.24
Margins
EBITDA margin
-7.6%
Gross margin
36.8%
Net margin
-21.9%
Operating margin
-18.2%
Efficiency
Return on assets
-9%
Return on equity
-12.8%
Return on invested capital
-24.7%
Return on capital employed
-9.4%
Return on sales
-19.8%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

OPK stock price

How has the Opko Health stock price performed over time
Intraday
-1.6%
1 week
-1.6%
1 month
27.51%
1 year
-15.75%
YTD
-18.54%
QTD
2.5%

Financial performance

How have Opko Health's revenue and profit performed over time
Revenue
$863.5M
Gross profit
$318.13M
Operating income
-$157.02M
Net income
-$188.86M
Gross margin
36.8%
Net margin
-21.9%
The net income is up by 42% year-on-year and by 9% since the previous quarter
The net margin has increased by 33% YoY and by 8% QoQ
The operating income has grown by 31% YoY but it has contracted by 10% from the previous quarter
Opko Health's gross margin has increased by 28% YoY but it has decreased by 3.2% from the previous quarter

Growth

What is Opko Health's growth rate over time

Valuation

What is Opko Health stock price valuation
P/E
N/A
P/B
0.68
P/S
1.07
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.24
Opko Health's EPS has increased by 46% YoY and by 11% from the previous quarter
The P/B is 38% below the 5-year quarterly average of 1.1 and 24% below the last 4 quarters average of 0.9
Opko Health's equity has decreased by 11% YoY and by 3.8% QoQ
The P/S is 24% below the 5-year quarterly average of 1.4 and 24% below the last 4 quarters average of 1.4
The company's revenue fell by 14% YoY

Efficiency

How efficient is Opko Health business performance
OPK's ROIC has soared by 54% year-on-year and by 15% since the previous quarter
Opko Health's ROS has increased by 48% YoY and by 15% from the previous quarter
The ROA has grown by 38% YoY and by 7% from the previous quarter
The ROE has increased by 36% YoY and by 6% QoQ

Dividends

What is OPK's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for OPK.

Financial health

How did Opko Health financials performed over time
Opko Health's quick ratio has decreased by 16% YoY and by 14% from the previous quarter
Opko Health's current ratio has decreased by 16% YoY and by 13% from the previous quarter
The debt is 78% lower than the equity
The debt to equity is up by 22% year-on-year and by 10% since the previous quarter
Opko Health's equity has decreased by 11% YoY and by 3.8% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.